Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings data on Monday. The medical research company reported $0.67 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05, Bloomberg Earnings reports. The company had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.17 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. Agilent Technologies’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.59 EPS. Agilent Technologies updated its Q1 guidance to $0.55-0.57 EPS and its FY18 guidance to $2.50-2.56 EPS.

Shares of Agilent Technologies (NYSE A) opened at $69.96 on Tuesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.76 and a current ratio of 3.22. The firm has a market capitalization of $22,520.00, a price-to-earnings ratio of 30.04, a P/E/G ratio of 2.70 and a beta of 1.28. Agilent Technologies has a 12 month low of $42.92 and a 12 month high of $70.23.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio is 27.32%.

In other Agilent Technologies news, CFO Didier Hirsch sold 1,200 shares of the stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total value of $79,200.00. Following the completion of the sale, the chief financial officer now directly owns 164,202 shares in the company, valued at $10,837,332. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $68.77, for a total value of $1,546,018.37. Following the completion of the sale, the chief executive officer now owns 336,637 shares of the company’s stock, valued at $23,150,526.49. The disclosure for this sale can be found here. Insiders have sold a total of 90,228 shares of company stock valued at $5,938,206 over the last 90 days.

Several equities analysts have commented on A shares. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a research report on Tuesday, October 31st. Robert W. Baird reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Agilent Technologies in a research report on Friday, October 20th. Cowen and Company reaffirmed a “hold” rating and issued a $65.00 price objective on shares of Agilent Technologies in a research report on Thursday, September 28th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research report on Wednesday, August 9th. Finally, BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 12th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Agilent Technologies currently has a consensus rating of “Buy” and an average price target of $67.20.

TRADEMARK VIOLATION NOTICE: “Agilent Technologies, Inc. (A) Announces Quarterly Earnings Results” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/11/21/agilent-technologies-inc-a-announces-quarterly-earnings-results.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Earnings History for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.